查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2018562

核酸萃取和純化市場：全球市場按產品類型、技術、樣品類型、應用和最終用戶分類的預測——2026-2032年

Nucleic Acid Isolation & Purification Market by Product Type, Technology, Sample Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，核酸分離純化市場價值將達到 82.4 億美元，到 2026 年將成長至 89.7 億美元，到 2032 年將達到 161.6 億美元，複合年成長率為 10.08%。

主要市場統計數據
基準年 2025 82.4億美元
預計年份：2026年 89.7億美元
預測年份 2032 161.6億美元
複合年成長率 (%) 10.08%

引言概述了核酸分離和純化在研究、診斷和治療方法開發流程中的策略重要性。

核酸萃取和純化是現代生命科學諸多工作流程的基礎，它能夠實現可靠的下游分子分析，從而推動發現、診斷和治療方法研發。自動化、化學和樣品處理技術的進步已經徹底改變了實驗室操作。同時，定序、基於PCR的檢測和臨床檢測的融合進一步凸顯了穩健且可重複的萃取平台的重要性。隨著實驗室優先考慮檢測能力、一致性和污染控制，樣品製備階段的選擇對數據品質和操作效率有著至關重要的影響。

詳細分析自動化、磁珠化學和整合工作流程如何改變核酸萃取實務和實驗室預期。

核酸分離純化領域經歷了變革性的變化，這主要得益於技術的成熟、工作流程的整合以及終端用戶需求的轉變。在許多中高通量環境中，自動化已從可選項變為必備要素，自動化工作站與磁珠化學技術的結合也日益增多，以確保結果的一致性、減少人工處理時間並實現可擴展的樣品處理。憑藉其柔軟性和自動化適應性，磁珠法如今已與柱層析法和過濾法並存，為檢查室提供了在速度、純度和單次樣品成本之間進行多種權衡的選擇。

對 2025 年美國實施的關稅措施如何影響供應鏈重組、採購政策轉變和庫存彈性策略進行全面評估。

2025年美國實施的政策調整和貿易措施為核酸萃取和純化的全球供應鏈帶來了新的不穩定性。關稅調整使到貨成本和交貨時間的前景更加明朗，影響了設備、試劑盒、試劑和耗材的籌資策略。為此，許多實驗室和供應商修訂了採購計劃，更加重視供應商多元化、確保本地庫存緩衝以及建立區域製造夥伴關係關係，以降低跨境關稅波動帶來的風險。

關鍵細分洞察揭示了產品類型、技術、樣品矩陣、應用重點和最終用戶需求如何相互交織，從而塑造產品策略和部署。

在核酸萃取和純化領域，了解市場區隔對於制定能夠滿足不同客戶需求的策略和商業性方案至關重要。區分產品類型至關重要，因為檢查室採購負責人會根據處理能力和驗證要求來選擇儀器、試劑盒、試劑和服務。儀器包括自動化工作站和純化系統，而試劑盒和試劑包括磁珠試劑盒和離心柱試劑盒，每種試劑盒都有不同的操作優缺點。將柱、過濾器、磁珠和沈澱方法等技術細分，可以決定其與下游檢測的兼容性、處理時間和與自動化平台的整合。血液、細胞和組織等樣本類型的不同，會對裂解、抑制劑去除和核酸完整性提出特定的基質要求，推動化學反應和方案的最佳化。

區域競爭考察和營運洞察：說明美洲、歐洲、中東和非洲以及亞太地區如何以獨特的方式推動採用趨勢和供應鏈優先事項。

區域趨勢對核酸分離純化領域的技術應用、法規遵循和供應鏈設計有顯著影響。在美洲，成熟的臨床診斷基礎設施和充足的研究經費推動了對檢驗的提取流程的需求，這些流程需與高通量定序和PCR平台整合。採購決策通常優先考慮結果出爐時間和法規遵循。歐洲、中東和非洲（EMEA）的情況則較為複雜。西歐部分地區優先考慮嚴格的法規遵循和檢查室認證，而該地區的新興市場則因臨床檢測能力的提升和研究投入的增加，對擴充性且經濟高效的提取解決方案的需求日益成長。在亞太地區，基因組研究的快速發展、臨床檢測網路的不斷擴展以及生物技術的蓬勃發展，推動了對自動化平台和本地化試劑供應的濃厚興趣。支持區域檢驗和服務網路擴展的夥伴關係也備受重視。

企業級策略洞察，展現產品創新、檢驗的工作流程和服務模式如何重塑競爭定位和商業策略。

核酸分離純化領域的主要企業正透過產品創新、策略夥伴關係和服務拓展結合的方式，維持獲利能力並深化客戶關係。許多供應商正投資於自動化化學試劑和模組化儀器設計，以降低不同規模實驗室採用這些技術的門檻。一個明確的策略重點是開發檢驗的工作流程，將萃取性能與下游檢測結果連結起來，使供應商能夠將產品定位為端到端解決方案，而非獨立的試劑或儀器。

製造商和服務供應商可以實施的實用建議，以加快部署速度、增強韌性並確保長期客戶價值。

產業領導企業可以採取多項切實可行的措施來增強韌性、加快部署速度，並使產品和服務適應不斷變化的實驗室需求。在設計儀器和試劑盒時，應優先考慮模組化自動化功能，以便客戶無需完全改變操作流程即可擴展產能。除了最佳化離心柱和沈澱方法外，還應投資最佳化磁珠化學，使產品系列能夠滿足各種樣品和產能需求。此外，還應加強關鍵應用（尤其是診斷和次世代定序）的技術檢驗方案，以便客戶能夠受益於更短的部署時間和更清晰的效能預測。

本文檔詳細介紹了一種高度透明的調查方法，包括一手調查、二手資料分析和檢驗程序，以確保可重複性和實用性。

本報告的研究基於多層次的調查方法，結合了質性研究和嚴謹的二手研究，並輔以結構化的檢驗，以得出可靠的結論。質性研究包括對學術研究中心、臨床診斷檢查室、受託研究機構（CRO）以及製藥和生物技術公司的實驗室經理、採購負責人和技術專家進行訪談。這些訪談揭示了在產能、檢驗和供應鏈方面切實可行的優先事項，並有助於檢驗從已發表的方案文獻和監管指導文件中得出的假設。

透過將技術進步、供應鏈現實和最終用戶期望整合到全面的結論中，我們闡明了相關人員。

總之，我們整合了以下關鍵主題：核酸分離純化處於技術創新與實際操作的交匯點，自動化、磁珠化學和整合工作流程正在推動其在科學研究和臨床領域的應用。終端使用者日益需要檢驗且擴充性的解決方案，以減少人工操作，同時確保核酸在諸如次世代定序和高靈敏度診斷檢測等高要求下游製程的完整性。供應鏈趨勢和區域差異進一步影響採購和部署策略，促使供應商和實驗室實現來源多元化並建立本地化支援系統。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 核酸萃取與純化市場：依產品類型分類

  • 裝置
    • 自動化工作站
    • 淨化設備
  • 試劑盒和試劑
    • 磁珠套裝
    • 旋轉柱套件
  • 服務

第9章 核酸萃取與純化市場：依技術分類

  • 柱子
  • 篩選
  • 磁珠
  • 降水法

第10章：核酸萃取和純化的市場樣本類型

  • 血
  • 細胞
  • 組織

第11章 核酸萃取與純化市場：依應用領域分類

  • 診斷
    • 癌症診斷
    • 基因疾病檢測
    • 感染疾病診斷
  • 基因表現分析
  • 次世代定序
    • 目標序列
    • 轉錄定序
    • 全基因組定序
  • PCR/RT-PCR

第12章 核酸萃取與純化市場：依最終用戶分類

  • 學術和研究機構
  • 臨床診斷檢查室
  • 合約研究機構
  • 製藥和生物技術公司

第13章 核酸萃取與純化市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 核酸萃取與純化市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 核酸萃取與純化市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國核酸萃取與純化市場

第17章：中國核酸萃取純化市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abcam plc
  • Agilent Technologies Inc.
  • Analytik Jena GmbH+Co. KG
  • Bio-Rad Laboratories Inc.
  • bioMerieux SA
  • BioSpring Gesellschaft fur Biotechnologie mbH
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Integrated DNA Technologies Inc.
  • LGC Limited
  • MACHEREY-NAGEL GmbH & Co. KG
  • Merck KGaA
  • New England Biolabs
  • Norgen Biotek Corp.
  • Omega Bio-tek Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN NV
  • Sartorius AG
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • TIANGEN BIOTECH BEIJING CO. LTD.
  • WuXi AppTec
  • Zymo Research Corporation
Product Code: MRR-783E443AFB64

The Nucleic Acid Isolation & Purification Market was valued at USD 8.24 billion in 2025 and is projected to grow to USD 8.97 billion in 2026, with a CAGR of 10.08%, reaching USD 16.16 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.24 billion
Estimated Year [2026] USD 8.97 billion
Forecast Year [2032] USD 16.16 billion
CAGR (%) 10.08%

Introduction framing the strategic importance of nucleic acid isolation and purification across research, diagnostics, and therapeutic development pipelines

Nucleic acid isolation and purification underpin many contemporary life sciences workflows, enabling reliable downstream molecular analyses that drive discovery, diagnostics, and therapeutic development. Advances in automation, chemistry, and sample processing have reshaped laboratory practices, while the convergence of sequencing, PCR-based assays, and clinical testing has elevated the profile of robust, reproducible extraction platforms. As laboratories prioritize throughput, consistency, and contamination control, the choices made at the sample preparation stage exert outsized influence on data quality and operational efficiency.

This introduction frames the broader landscape by situating isolation and purification processes within three operational axes: technology selection and adoption; product and service delivery models; and end-user needs across academic, clinical, and industry laboratories. It emphasizes how innovations-such as magnetic bead chemistry and automated workstations-interact with regulatory expectations and shifting laboratory footprints. By clarifying terminology and use cases, this section sets the stage for more detailed discussion of transformative shifts, tariff impacts, segmentation insights, regional dynamics, company strategies, and actionable recommendations for stakeholders seeking to optimize capacity and resilience.

Detailed exploration of how automation, magnetic bead chemistry, and integrated workflows are reshaping nucleic acid extraction practices and laboratory expectations

The landscape of nucleic acid isolation and purification has undergone a transformative shift driven by technological maturation, workflow integration, and changing end-user priorities. Automation has moved from optional to essential in many mid-to-high throughput settings, with automated workstations increasingly paired with magnetic bead chemistries to deliver consistency, reduce hands-on time, and enable scalable sample processing. Magnetic bead approaches, favored for flexibility and amenability to automation, now coexist with column and filter methods, offering laboratories a spectrum of trade-offs between speed, purity, and cost per sample.

Concurrently, sample diversity and application complexity have reshaped product development. Clinical diagnostics and next generation sequencing exert high demands for nucleic acid integrity and inhibitor removal, incentivizing suppliers to optimize chemistries for blood, cellular, and tissue matrices. Kits and reagents are evolving to support targeted sequencing, transcriptomics, and whole genome applications, while instrument manufacturers focus on modularity to accommodate diverse throughput needs. Alongside technological evolution, service models have shifted: contract research organizations and core facilities increasingly offer standardized extraction services that lower barriers for smaller labs. Taken together, these trends signal a transition from point-solution extraction tools toward integrated, validated workflows designed to meet reproducibility, regulatory, and scale requirements.

Comprehensive assessment of how United States tariff measures introduced in 2025 catalyzed supply chain reengineering, procurement shifts, and inventory resilience strategies

Policy shifts and trade actions originating in the United States in 2025 introduced new variables into global supply chains that intersect with nucleic acid isolation and purification. Tariff adjustments influenced procurement strategies for instruments, kits, reagents, and consumables by increasing the visibility of landed costs and delivery lead times. In response, many laboratories and suppliers reassessed sourcing plans, placing greater emphasis on supplier diversification, local inventory buffers, and regional manufacturing partnerships to mitigate exposure to cross-border tariff volatility.

The tariff environment also accelerated conversations about supply chain resilience versus cost optimization. Procurement teams weighed the trade-offs inherent in maintaining larger domestic inventories against the cashflow impacts and storage requirements. Meanwhile, some suppliers pursued nearshoring and reconfiguration of distribution networks to preserve delivery reliability to clinical diagnostics laboratories and contract research organizations that cannot tolerate interruptions. Regulatory conformity and quality management remained non-negotiable, prompting investments in documentation and validation to support alternative sourcing. Overall, the tariffs acted as a catalyst for strategic supply chain reengineering and served to highlight the importance of agility, transparency, and long-term supplier collaboration in preserving uninterrupted access to critical extraction products and services.

Key segmentation insights revealing how product type, technology, sample matrix, application focus, and end-user needs converge to shape product strategies and adoption

Understanding segmentation is essential to crafting product strategies and commercial approaches that resonate with diverse customer needs across the nucleic acid isolation and purification space. Product type distinctions matter because laboratory buyers choose between instruments, kits and reagents, and services based on throughput and validation requirements; instruments span automated workstations and purification instruments, while kits and reagents include magnetic bead kits and spin column kits that present different operational trade-offs. Technology segmentation-covering column, filter, magnetic bead, and precipitation methods-shapes downstream assay compatibility, hands-on time, and integration with automation platforms. Sample type considerations such as blood, cells, and tissue impose matrix-specific demands on lysis, inhibitor removal, and nucleic acid integrity, driving the optimization of chemistries and protocols.

Application-driven segmentation further differentiates buyer priorities, with diagnostics, gene expression analysis, next generation sequencing, and PCR/RT-PCR each imposing distinct performance and validation criteria. Within diagnostics, needs diverge across cancer diagnostics, genetic disorder testing, and infectious disease diagnostics, each requiring tailored workflows that balance sensitivity, specificity, and turnaround time. Next generation sequencing splits into targeted sequencing, transcriptome sequencing, and whole genome sequencing, where input quality and fragment size considerations influence extraction choice. End-user segmentation highlights differences in procurement cycles and adoption pathways: academic and research institutes prize flexibility and method transparency; clinical diagnostics laboratories demand stringent validation and continuity; contract research organizations prioritize throughput and reproducibility; and pharmaceutical and biotechnology companies require scalable, GMP-aligned workflows. These intersecting segmentations inform product roadmaps, go-to-market tactics, and services that support adoption and validation across distinct laboratory environments.

Regional competitive and operational insights explaining how the Americas, Europe Middle East & Africa, and Asia-Pacific uniquely drive adoption and supply chain priorities

Regional dynamics exert a pronounced influence on technology adoption, regulatory alignment, and supply chain design across the nucleic acid isolation and purification domain. In the Americas, mature clinical diagnostics infrastructure and robust research funding foster demand for validated extraction workflows that integrate with high-throughput sequencing and PCR platforms; procurement decision-making often prioritizes time-to-result and regulatory conformity. Europe, Middle East & Africa present a heterogeneous landscape: parts of Western Europe emphasize stringent regulatory compliance and laboratory accreditation, while emerging markets within the region exhibit growing demand driven by expanding clinical testing capabilities and research investments, necessitating scalable and cost-effective extraction solutions. In Asia-Pacific, rapid investment in genomic research, expanding clinical testing networks, and a burgeoning biotechnology sector drive strong interest in automated platforms and localized reagent supply, alongside an emphasis on partnerships that support regional validation and service coverage.

Across these regions, differences in reimbursement frameworks, procurement cycles, and laboratory infrastructure influence which technologies and business models succeed. Regional manufacturing and distribution capabilities play an outsized role in ensuring timely access to consumables and instruments, particularly for high-volume clinical testing. As a result, suppliers increasingly tailor commercial approaches by region, combining localized technical support and validation resources with flexible logistics solutions to meet the divergent needs of academic centers, clinical laboratories, CROs, and industry customers.

Strategic company-level insights showing how product innovation, validated workflows, and service models are reshaping competitive positioning and commercial tactics

Leading companies in the nucleic acid isolation and purification ecosystem are pursuing a combination of product innovation, strategic partnerships, and service expansion to protect margins and deepen customer relationships. Many suppliers are investing in automation-compatible chemistries and modular instrument designs that reduce barriers to adoption across laboratories of varying scale. There is a clear strategic emphasis on developing validated workflows that link extraction performance to downstream assay outcomes, enabling vendors to position their offerings as end-to-end solutions rather than isolated reagents or devices.

Commercial tactics include strengthening distribution networks, expanding technical support and training offerings, and providing application-specific validation packages for clinical and research customers. Suppliers are also exploring subscription and consumable-based revenue models to stabilize demand and enhance predictability. In parallel, some companies are building or partnering with service organizations to offer extraction-as-a-service, which addresses capacity constraints for customers and generates differentiated revenue streams. Across these maneuvers, intellectual property in reagent formulations, instrument automation algorithms, and quality systems remains a competitive differentiator that supports premium positioning in regulated markets.

Actionable recommendations that manufacturers and service providers can implement to accelerate adoption, enhance resilience, and secure long-term customer value

Industry leaders can take several practical actions to strengthen resilience, accelerate adoption, and align offerings with evolving laboratory needs. Prioritize modular automation compatibility when designing instruments and kits so that customers can scale throughput without wholesale protocol changes. Invest in magnetic bead chemistry optimization alongside spin column and precipitation options to ensure product portfolios meet a variety of sample and throughput requirements. Strengthen technical validation packages for key applications-particularly diagnostics and next generation sequencing-so customers benefit from reduced implementation time and clearer performance expectations.

From a commercial perspective, cultivate regional supply chain flexibility by establishing multiple sourcing options and localized distribution agreements to guard against tariff and logistics disruptions. Expand value-added services such as method transfer support, on-site training, and extraction-as-a-service offerings to deepen customer engagement and create recurring revenue. Finally, enhance transparency around quality management and regulatory documentation to support clinical adoption and accelerate procurement decisions in regulated environments. These combined actions will help organizations capture demand driven by automation, complex applications, and an increased emphasis on reproducibility and regulatory compliance.

Transparent research methodology detailing primary engagement, secondary synthesis, and validation steps used to ensure reproducible and actionable insights

The research underpinning this report relied on a multilayered methodological approach combining primary qualitative engagement and rigorous secondary analysis, supplemented by structured triangulation to ensure robust conclusions. Primary research included interviews with laboratory leaders, procurement officers, and technical specialists across academic research centers, clinical diagnostics laboratories, contract research organizations, and pharmaceutical and biotechnology companies. These conversations illuminated real-world priorities around throughput, validation, and supply chain concerns, and served to validate assumptions drawn from published protocol literature and regulatory guidance documents.

Secondary research encompassed a systematic review of peer-reviewed journals, industry white papers, technical application notes, and public regulatory filings to map technology performance characteristics and application suitability. Data synthesis involved cross-referencing insights across sources to identify convergent themes and reconcile discrepancies. Quality assurance protocols included multiple rounds of internal review, expert validation, and methodological transparency with documented interview guides and inclusion criteria. The result is a research foundation that emphasizes reproducibility, applicability to diverse end-users, and practical relevance for decision-makers evaluating nucleic acid isolation and purification strategies.

Concluding synthesis that integrates technological advances, supply chain realities, and end-user expectations to clarify strategic imperatives for stakeholders

The conclusion synthesizes the principal themes: nucleic acid isolation and purification are at the intersection of technological innovation and operational pragmatism, where automation, magnetic bead chemistry, and integrated workflows drive adoption across research and clinical settings. End-users increasingly demand validated, scalable solutions that reduce hands-on time while safeguarding nucleic acid integrity for demanding downstream applications such as next generation sequencing and sensitive diagnostic assays. Supply chain dynamics and regional variations further influence procurement and deployment strategies, encouraging suppliers and laboratories to pursue diversified sourcing and localized support structures.

Looking forward, stakeholders who align product development with modular automation, application-specific validation, and resilient supply networks will be best positioned to meet evolving laboratory requirements. Strategic investments in service offerings and regional presence will complement product innovation, enabling sustained customer partnerships and operational continuity. These conclusions underscore that success in this domain is as much about dependable execution and customer support as it is about technical performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Nucleic Acid Isolation & Purification Market, by Product Type

  • 8.1. Instruments
    • 8.1.1. Automated Workstations
    • 8.1.2. Purification Instruments
  • 8.2. Kits & Reagents
    • 8.2.1. Magnetic Bead Kits
    • 8.2.2. Spin Column Kits
  • 8.3. Services

9. Nucleic Acid Isolation & Purification Market, by Technology

  • 9.1. Column
  • 9.2. Filter
  • 9.3. Magnetic Bead
  • 9.4. Precipitation

10. Nucleic Acid Isolation & Purification Market, by Sample Type

  • 10.1. Blood
  • 10.2. Cells
  • 10.3. Tissue

11. Nucleic Acid Isolation & Purification Market, by Application

  • 11.1. Diagnostics
    • 11.1.1. Cancer Diagnostics
    • 11.1.2. Genetic Disorder Testing
    • 11.1.3. Infectious Disease Diagnostics
  • 11.2. Gene Expression Analysis
  • 11.3. Next Generation Sequencing
    • 11.3.1. Targeted Sequencing
    • 11.3.2. Transcriptome Sequencing
    • 11.3.3. Whole Genome Sequencing
  • 11.4. PCR RT-PCR

12. Nucleic Acid Isolation & Purification Market, by End User

  • 12.1. Academic & Research Institutes
  • 12.2. Clinical Diagnostics Laboratories
  • 12.3. Contract Research Organizations
  • 12.4. Pharmaceutical & Biotechnology Companies

13. Nucleic Acid Isolation & Purification Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Nucleic Acid Isolation & Purification Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Nucleic Acid Isolation & Purification Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Nucleic Acid Isolation & Purification Market

17. China Nucleic Acid Isolation & Purification Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abcam plc
  • 18.6. Agilent Technologies Inc.
  • 18.7. Analytik Jena GmbH+Co. KG
  • 18.8. Bio-Rad Laboratories Inc.
  • 18.9. bioMerieux SA
  • 18.10. BioSpring Gesellschaft fur Biotechnologie mbH
  • 18.11. Danaher Corporation
  • 18.12. F. Hoffmann-La Roche Ltd.
  • 18.13. Illumina Inc.
  • 18.14. Integrated DNA Technologies Inc.
  • 18.15. LGC Limited
  • 18.16. MACHEREY-NAGEL GmbH & Co. KG
  • 18.17. Merck KGaA
  • 18.18. New England Biolabs
  • 18.19. Norgen Biotek Corp.
  • 18.20. Omega Bio-tek Inc.
  • 18.21. PerkinElmer Inc.
  • 18.22. Promega Corporation
  • 18.23. QIAGEN N.V.
  • 18.24. Sartorius AG
  • 18.25. Takara Bio Inc.
  • 18.26. Thermo Fisher Scientific Inc.
  • 18.27. TIANGEN BIOTECH BEIJING CO. LTD.
  • 18.28. WuXi AppTec
  • 18.29. Zymo Research Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PURIFICATION INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PURIFICATION INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PURIFICATION INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SPIN COLUMN KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SPIN COLUMN KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SPIN COLUMN KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COLUMN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COLUMN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COLUMN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY FILTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY FILTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY FILTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRECIPITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRECIPITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRECIPITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENETIC DISORDER TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENETIC DISORDER TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENETIC DISORDER TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PCR RT-PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PCR RT-PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PCR RT-PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. GCC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. GCC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. GCC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 190. GCC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 191. GCC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. GCC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 195. GCC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 196. GCC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. G7 NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. G7 NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. G7 NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 220. G7 NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 221. G7 NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. G7 NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. G7 NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. G7 NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 225. G7 NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 226. G7 NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. NATO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. NATO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. NATO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 230. NATO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 231. NATO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 232. NATO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. NATO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. NATO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 235. NATO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 236. NATO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)